ボトックスの世界市場レポート 2025年：疫学、パイプライン分析、市場インサイトと予測

ボトックスの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR10％で80億4,960万米ドルに成長します。予測期間の成長は、美容治療に対する需要の増加、低侵襲・非侵襲処置に対する需要の増加、低侵襲・非侵襲処置に対する需要の増加、注射による美容処置に対する需要の増加、認知度・受容度の増加に起因すると考えられます。予測期間における主要動向としては、多数の製品の承認、オーダーメイドのソリューションを提供することによる男性美容への注力、革新的な製品の発売、開発のための製薬企業間の協力、ボツリヌス毒素製剤の進歩などが挙げられます。

美容整形に対する需要の高まりは、ボトックス市場の成長を大きく促進すると予想されます。美容施術は主に、低侵襲技術の進歩、ソーシャルメディアからの影響力の増大、社会的受容の拡大に助けられた、美的向上への欲求の高まりによって煽られています。美容治療の需要は、より安全で低侵襲な技術の進歩や可処分所得の増加によってさらに支えられています。美容治療への幅広いアクセスとともに、外見の基準を形成するソーシャルメディアの役割が、この動向に寄与しています。ボトックスは、顔の筋肉を一時的に弛緩させ、シワ、小ジワ、カラスの足跡を目立たなくし、より滑らかで若々しい外見を提供することで、これらの施術において重要な役割を果たしています。国際美容整形外科学会（ISAPS）によると、2023年には世界で3,490万件の美容整形手術が行われ、2022年から3.4％増加しました。このような美容整形に対する需要の高まりが、ボトックス市場の拡大に拍車をかけています。

ボトックス市場の主要動向は、神経毒をベースとした製品などのイノベーションの開発です。これらの製品は、特定の筋肉群を対象とし、治療精度を向上させ、美容と治療の両方の用途でボトックスの使用を拡大するように設計されています。神経毒は、神経伝達物質の放出を阻害することで神経機能を抑制し、過剰に活動する筋肉を弛緩させ、シワを減らすのに効果的です。例えば、2023年1月、Evolus, Inc.は、その神経毒製品Nuceiva（プラボツリヌムトキシンA）について、オーストラリア治療品庁（TGA）から薬事承認を取得しました。Nuceivaは、成人の中等度から重度の目尻のシワを一時的に改善することを目的としています。A型ボツリヌス毒素に由来するこの製品は、筋肉の収縮に関与するアセチルコリンの放出をブロックすることで作用します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 バイオ医薬品市場における製品特性

• 分子タイプ
• 投与経路（ROA）
• 作用機序（MOA）
• 安全性と有効性

第4章 市場動向と戦略

第5章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第6章 世界の成長分析と戦略分析フレームワーク

• 世界のボトックス：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のボトックス市場：成長率分析
• 世界のボトックス市場の実績：規模と成長、2019～2024年
• 世界のボトックス市場の予測：規模と成長、2024～2029年、2034年
• 世界のボトックス：総潜在市場規模（TAM）

第7章 世界市場の価格分析と予測

第8章 市場セグメンテーション

• 世界のボトックス市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ボツリヌス毒素A型
• ボツリヌス毒素B型
• 世界のボトックス市場：疾患別、実績と予測、2019～2024年、2024～2029年、2034年
• 慢性片頭痛
• 頸部ジストニア
• 眼瞼けいれん
• 過活動膀胱（OAB）
• 顎関節症（TMJ）
• 世界のボトックス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 治療
• 美容
• 世界のボトックス市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 専門クリニック
• 皮膚科クリニック
• その他

第9章 臨床適応症の世界市場疫学

• 薬剤の副作用
• 臨床適応症の発症率と有病率

第10章 地域別・国別分析

• 世界のボトックス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のボトックス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第11章 アジア太平洋市場

第12章 中国市場

第13章 インド市場

第14章 日本市場

第15章 オーストラリア市場

第16章 韓国市場

第17章 西欧市場

第18章 英国市場

第19章 ドイツ市場

第20章 フランス市場

第21章 東欧市場

第22章 北米市場

第23章 米国市場

第24章 カナダ市場

第25章 南米市場

第26章 中東市場

第27章 アフリカ市場

第28章 競合情勢と企業プロファイル

• ボトックス市場：競合情勢
• ボトックス市場：企業プロファイル
  • AbbVie
  • Ipsen
  • Evolus
  • Hugel
  • Galderma

第29章 世界市場：パイプライン分析

第30章 世界の市場競合ベンチマーキングとダッシュボード

第31章 主要な合併と買収

第32章 最近の市場動向

第33章 市場の潜在力が高い国、戦略

• ボトックス市場、2029年：新たな機会を提供する国
• ボトックス市場、2029年：新たな機会を提供するセグメント
• ボトックス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第34章 付録

Botox is a purified form of botulinum toxin type A, a neurotoxin produced by the bacterium Clostridium botulinum. Botox works by blocking nerve signals to muscles, preventing them from contracting. This property makes it a versatile and widely recognized treatment in both medical and aesthetic fields.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types in the botox market are botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is used to block acetylcholine release for treating conditions such as chronic sialorrhea, muscle spasticity, and dystonia, in addition to its use in various cosmetic treatments. The applications include both therapeutic and aesthetic purposes, with end users ranging from hospitals and specialty clinics to dermatology clinics and other healthcare providers.

The botox market research report is one of a series of new reports from The Business Research Company that provides botox market statistics, including botox industry global market size, regional shares, competitors with a botox market share, detailed botox market segments, market trends, and opportunities, and any further data you may need to thrive in the botox industry. This botox market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The botox market size is expected to see rapid growth in the next few years. It will grow to $8,049.6 million in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to growing demand for aesthetic therapeutics, increasing demand for minimally invasive and non-invasive procedures, increasing demand for minimally invasive and non-invasive procedures, increasing demand for injectable aesthetic procedures, and increasing awareness and acceptance. Major trends in the forecast period include approval of large number of products, focusing on male aesthetics by offering tailored solutions, innovative product launches, collaboration between pharmaceutical companies for development, and advancements in botulinum toxin formulations.

The rising demand for cosmetic procedures is expected to significantly drive the growth of the botox market. Cosmetic procedures are primarily fueled by the growing desire for aesthetic enhancement, aided by advancements in minimally invasive techniques, increased influence from social media, and greater societal acceptance. The demand for cosmetic treatments is further supported by advancements in safer, minimally invasive technologies and rising disposable incomes. Social media's role in shaping appearance standards, alongside broader access to aesthetic treatments, is contributing to this trend. Botox plays a crucial role in these procedures by temporarily relaxing facial muscles to reduce the appearance of wrinkles, fine lines, and crow's feet, offering a smoother and more youthful appearance. According to the International Society of Aesthetic Plastic Surgery (ISAPS), 34.9 million aesthetic procedures were performed globally in 2023, a 3.4% increase from 2022. This growing demand for cosmetic procedures is fueling the botox market's expansion.

A key trend in the botox market is the development of innovations such as neurotoxin-based products, which are designed to target specific muscle groups, improve treatment precision, and expand the use of Botox in both aesthetic and therapeutic applications. Neurotoxins inhibit nerve function by blocking neurotransmitter release, making them effective in relaxing overactive muscles and reducing wrinkles. For example, in January 2023, Evolus, Inc. received regulatory approval for its neurotoxin product, Nuceiva (prabotulinumtoxinA), from the Australian Therapeutic Goods Administration (TGA). Nuceiva is aimed at temporarily improving the appearance of moderate to severe glabellar lines in adults. This product, derived from botulinum toxin type A, works by blocking acetylcholine release, which is responsible for muscle contraction.

In February 2022, Healis Therapeutics, a US-based biotechnology company, acquired an exclusive license for a botulinum toxin patent from AbbVie. The partnership focuses on developing a botulinum toxin candidate for treating major depressive disorder (MDD), showcasing Botox's growing therapeutic applications beyond cosmetic use.

Major players operating in the botox market are AbbVie, Ipsen, Evolus, Hugel, Galderma, Revance Therapeutics, Croma Pharma, and Merz Pharmaceuticals

North America was the largest region in the Botox market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in botox report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the botox market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botox market consists of sales of dysport, xeomin, and jeuveau. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botox Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botox market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botox ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botox market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
• 2) By Clinical Indication: Chronic Migraine; Cervical Dystonia; Blepharospasm; Overactive Bladder (OAB); Temporomandibular Joint (TMJ) Disorders
• 2) By Application: Therapeutics; Aesthetics
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Companies Mentioned: AbbVie; Ipsen; Evolus; Hugel; Galderma; Revance Therapeutics; Croma Pharma; Merz Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botox Market Characteristics

3. Botox Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Botox Market Trends And Strategies

5. Botox Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Botox Growth Analysis And Strategic Analysis Framework

• 6.1. Global Botox PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Botox Market Growth Rate Analysis
• 6.4. Global Botox Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Botox Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Botox Total Addressable Market (TAM)

7. Global Botox Market Pricing Analysis & Forecasts

8. Botox Market Segmentation

• 8.1. Global Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botulinum Toxin Type A
• Botulinum Toxin Type B
• 8.2. Global Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Migraine
• Cervical Dystonia
• Blepharospasm
• Overactive Bladder (OAB)
• Temporomandibular Joint (TMJ) Disorders
• 8.3. Global Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Aesthetics
• 8.4. Global Botox Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users

9. Global Botox Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Botox Market Regional And Country Analysis

• 10.1. Global Botox Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Botox Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Botox Market

• 11.1. Asia-Pacific Botox Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Botox Market

• 12.1. China Botox Market Overview
• 12.2. China Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Botox Market

• 13.1. India Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Botox Market

• 14.1. Japan Botox Market Overview
• 14.2. Japan Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Botox Market

• 15.1. Australia Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Botox Market

• 16.1. South Korea Botox Market Overview
• 16.2. South Korea Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Botox Market

• 17.1. Western Europe Botox Market Overview
• 17.2. Western Europe Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Botox Market

• 18.1. UK Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Botox Market

• 19.1. Germany Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Botox Market

• 20.1. France Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Botox Market

• 21.1. Eastern Europe Botox Market Overview
• 21.2. Eastern Europe Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Botox Market

• 22.1. North America Botox Market Overview
• 22.2. North America Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Botox Market

• 23.1. USA Botox Market Overview
• 23.2. USA Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Botox Market

• 24.1. Canada Botox Market Overview
• 24.2. Canada Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Botox Market

• 25.1. South America Botox Market Overview
• 25.2. South America Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Botox Market

• 26.1. Middle East Botox Market Overview
• 26.2. Middle East Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Botox Market

• 27.1. Africa Botox Market Overview
• 27.2. Africa Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Botox Market Competitive Landscape And Company Profiles

• 28.1. Botox Market Competitive Landscape
• 28.2. Botox Market Company Profiles
  • 28.2.1. AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Ipsen Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. Evolus Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.4. Hugel Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.5. Galderma Overview, Products and Services, Strategy and Financial Analysis

29. Global Botox Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Botox Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Botox Market

32. Recent Developments In The Botox Market

33. Botox Market High Potential Countries, Segments and Strategies

• 33.1 Botox Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Botox Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Botox Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer